Studies on deep fungal infections in cancer patients

This study included one hundred and ten tumour cases [tested group]. Also, twenty non tumor cases [control group]. All were subjected to four samples taken from each case, blood, sputum, urine and stool for isolation of possible fungi. The tested group was divided into 3 sub-groups according to the type of tumour. Group I. Haematological tumours [8 cases], Group II Lymphoproliferative tumours [10 cases] and Group III Solid organ tumours [84 tumours]. The most prevalent type of fungi was found in Group III. Most infections occur in respiratory tract infection. The fungal in these cases accounts for 12 types of fungi followed by, gastrointestinal fungal infections which accounts for 10 types of fungi and then to urinary tract fungal infections which accounts for 5 types of fungi. The most prevalent fungi in respiratory tract infections were C. albicans. Which was isolated from 52 cases of 84 cases with a percentage of 62%. In gastrointestinal infections were 36 cases of a total 86 positive cases with a percentage of 42%. The infected control cases were in 6 cases of 20' positive cases [30%]. In urinary tract infections 12 cases of 24 positive cases with a percentage of [50%] while; control cases were negative. The following most prevalent fungi in respiratory-tract infections was C.pseudotropicalis. It was isolated from 16 cases of 84 cases with a percentage of [19%]. Gastrointestinal infections were 20 cases of a total 86 positive cases with a percentage of [23%]. In urinary tract infections 6 cases of 24 positive cases with a percentage of [25%]. C.tropicalis infection of respiratory tract was in 12 cases of a total 84 with a percentage of [14%] and in gastrointestinal infections was 12 cases of a total 86 cases with a percentage of [14%]. Asp. Niger represent 9.5% [8/84] of respiratory tract infections while; control cases accounts for 20%. In gastrointestinal infections, Asp. Niger represent [2.4%] while controls was 2 of 20 positive cases [10%]. The same fungus represent 8.3%' [2/24] in urinary tract infections. Negative control cases in urinary tract infections